Community Practice Connections™: Expert Illustrations and Commentaries: Nephrology Nurse Perspectives in Anemia in CKD
July 1, 2022
July 1, 2023
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grant from GlaxoSmithKline.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
- Nurses — 1.0 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
This educational activity is directed toward nephrology nurses. Primary care physicians and nephrologists who treat anemia in CKD will also be invited to participate in the online enduring activity.
For patients with chronic kidney disease (CKD), anemia is associated with major complications, including impaired cognition, sleep disturbance, increased cardiac risk, lower quality of life, and increased medical expenses. Conventional treatment of anemia in these patients has focused on the use of exogenously administered erythropoietin with intravenous iron, as required. Whereas the benefits of such therapy are well-established, there are several limitations, including increased risks of cardiovascular and cerebrovascular events. New agents are in late-stage development that may address some of the shortcomings of the conventional treatments for CKD. Fundamental changes in the clinical paradigm of treating CKD will occur as more of these agents are approved.
This Community Practice Connection™ program provides an in-depth review of some of the key highlights from Expert Illustrations and Commentaries Live: Nephrology Nurse Perspectives in Anemia in CKD, held in May 2022. This unique and engaging multimedia activity is ideal for the community-based clinician; it focuses on the practical aspects of managing patients with anemia and CKD, putting recent clinical trial data into a clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
Upon completion of this activity, participants should be better able to:
- Describe the clinical burden of anemia in patients with chronic kidney disease
- Discuss the pathophysiology of anemia in chronic kidney disease, including therapeutic targets
- Apply current assessment strategies to accurately diagnose patients with anemia and chronic kidney disease based on clinical presentation
- Develop appropriate therapeutic regimens for patients with anemia and chronic kidney disease based on goals of therapy
Jane S. Davis, CRNP, DNP
University of Alabama at Birmingham
Jean Colaneri, ACNP-BC, CNN-NP
Nurse Practitioner/Nurse Clinician
Acute Adult and Chronic Pediatric Program
Albany Medical Center Hospital
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
- Jane S. Davis, CRNP, DNP
- Speaker’s Bureau: Amgen (for Calcimimetics), Bayer
Jean Colaneri, ACNP-BC, CNN-NP, has no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.